Swati Dhar

1.1k total citations
22 papers, 866 citations indexed

About

Swati Dhar is a scholar working on Molecular Biology, Oncology and Geriatrics and Gerontology. According to data from OpenAlex, Swati Dhar has authored 22 papers receiving a total of 866 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 9 papers in Oncology and 7 papers in Geriatrics and Gerontology. Recurrent topics in Swati Dhar's work include Histone Deacetylase Inhibitors Research (9 papers), Sirtuins and Resveratrol in Medicine (7 papers) and MicroRNA in disease regulation (5 papers). Swati Dhar is often cited by papers focused on Histone Deacetylase Inhibitors Research (9 papers), Sirtuins and Resveratrol in Medicine (7 papers) and MicroRNA in disease regulation (5 papers). Swati Dhar collaborates with scholars based in United States, India and Germany. Swati Dhar's co-authors include Anait S. Levenson, Avinash Kumar, Agnes M. Rimando, Kun Li, Chindo Hicks, Shubhada Chiplunkar, Xu Zhang, Jack R. Lewin, Alan D. Penman and Guri Tzivion and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Cancer Research.

In The Last Decade

Swati Dhar

22 papers receiving 849 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Swati Dhar United States 15 566 284 258 210 121 22 866
Valentina Grossi Italy 17 647 1.1× 221 0.8× 68 0.3× 216 1.0× 82 0.7× 49 1.0k
Madhavi Sekharam United States 11 452 0.8× 112 0.4× 64 0.2× 328 1.6× 133 1.1× 14 789
Toran Sanli Canada 10 769 1.4× 328 1.2× 65 0.3× 290 1.4× 44 0.4× 12 986
Belén Santiago‐Josefat Spain 10 357 0.6× 139 0.5× 106 0.4× 190 0.9× 48 0.4× 10 673
Yingze Wei China 15 376 0.7× 142 0.5× 75 0.3× 98 0.5× 54 0.4× 24 574
Peng Meng China 13 383 0.7× 171 0.6× 57 0.2× 140 0.7× 43 0.4× 22 649
Young Gyoon Chang South Korea 11 752 1.3× 392 1.4× 159 0.6× 171 0.8× 39 0.3× 12 995
Mercedes Nadal‐Serrano Spain 16 391 0.7× 132 0.5× 39 0.2× 316 1.5× 33 0.3× 23 830
Jingjie Yi United States 9 303 0.5× 91 0.3× 144 0.6× 118 0.6× 32 0.3× 10 485
Kathryn J. Huber-Keener United States 11 331 0.6× 97 0.3× 125 0.5× 88 0.4× 38 0.3× 17 584

Countries citing papers authored by Swati Dhar

Since Specialization
Citations

This map shows the geographic impact of Swati Dhar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Swati Dhar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Swati Dhar more than expected).

Fields of papers citing papers by Swati Dhar

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Swati Dhar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Swati Dhar. The network helps show where Swati Dhar may publish in the future.

Co-authorship network of co-authors of Swati Dhar

This figure shows the co-authorship network connecting the top 25 collaborators of Swati Dhar. A scholar is included among the top collaborators of Swati Dhar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Swati Dhar. Swati Dhar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wolfarth, Alexandra A., et al.. (2022). Advancements of Common Gamma-Chain Family Cytokines in Cancer Immunotherapy. Immune Network. 22(1). e5–e5. 13 indexed citations
2.
Wolfarth, Alexandra A., et al.. (2022). The Role of Interleukin-7 in the Formation of Tertiary Lymphoid Structures and Their Prognostic Value in Gastrointestinal Cancers. SHILAP Revista de lepidopterología. 5(4). 105–117. 10 indexed citations
3.
Dhar, Swati, Samantha Gadd, Priyam Patel, et al.. (2022). A tumor suppressor role for EZH2 in diffuse midline glioma pathogenesis. Acta Neuropathologica Communications. 10(1). 47–47. 25 indexed citations
4.
Naing, Aung, Michael Ware, Cara Haymaker, et al.. (2022). 657 NT-I7, a long-acting IL-7, plus pembrolizumab favors CD8 T-cell infiltration in liver metastases of heavily pre-treated, immunologically cold, MSS-colorectal and pancreatic cancer. Regular and Young Investigator Award Abstracts. A688–A688. 2 indexed citations
5.
Kumar, Avinash, et al.. (2018). MTA1 drives malignant progression and bone metastasis in prostate cancer. Molecular Oncology. 12(9). 1596–1607. 25 indexed citations
6.
Kumar, Avinash, Swati Dhar, Agnes M. Rimando, et al.. (2017). Targeting MTA1/HIF-1alpha Signaling by Pterostilbene in Combination with Histone Deacetylase Inhibitor Attenuates Prostate Cancer Progression (Open Access). 7 indexed citations
7.
Kumar, Avinash, Swati Dhar, Agnes M. Rimando, et al.. (2017). Targeting MTA1/HIF‐1α signaling by pterostilbene in combination with histone deacetylase inhibitor attenuates prostate cancer progression. Cancer Medicine. 6(11). 2673–2685. 39 indexed citations
8.
Dhar, Swati, Avinash Kumar, Christian R. Gómez, et al.. (2017). MTA1‐activated Epi‐microRNA‐22 regulates E‐cadherin and prostate cancer invasiveness. FEBS Letters. 591(6). 924–933. 36 indexed citations
9.
Dhar, Swati, Avinash Kumar, Liangfen Zhang, et al.. (2016). Dietary pterostilbene is a novel MTA1-targeted chemopreventive and therapeutic agent in prostate cancer. Oncotarget. 7(14). 18469–18484. 51 indexed citations
10.
Kumar, Avinash, Swati Dhar, Agnes M. Rimando, et al.. (2015). Epigenetic potential of resveratrol and analogs in preclinical models of prostate cancer. Annals of the New York Academy of Sciences. 1348(1). 1–9. 38 indexed citations
11.
Dhar, Swati, Avinash Kumar, Agnes M. Rimando, Xu Zhang, & Anait S. Levenson. (2015). Resveratrol and pterostilbene epigenetically restore PTEN expression by targeting oncomiRs of the miR-17 family in prostate cancer. Oncotarget. 6(29). 27214–27226. 124 indexed citations
12.
Dhar, Swati, Avinash Kumar, Kun Li, Guri Tzivion, & Anait S. Levenson. (2014). Resveratrol regulates PTEN/Akt pathway through inhibition of MTA1/HDAC unit of the NuRD complex in prostate cancer. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research. 1853(2). 265–275. 103 indexed citations
13.
Zhang, Liangfen, Swati Dhar, Agnes M. Rimando, et al.. (2014). Abstract 3199: Pterostilbene supresses prostate cancer progression in transgenic mice model. Cancer Research. 74(19_Supplement). 3199–3199. 1 indexed citations
14.
Zhou, Xinchun, Marina Ivanovic, Michael P. Gailey, et al.. (2013). Nuclear MTA1 overexpression is associated with aggressive prostate cancer, recurrence and metastasis in African Americans. Scientific Reports. 3(1). 2331–2331. 39 indexed citations
15.
Li, Kun, Agnes M. Rimando, Swati Dhar, et al.. (2013). Pterostilbene Acts through Metastasis-Associated Protein 1 to Inhibit Tumor Growth, Progression and Metastasis in Prostate Cancer. PLoS ONE. 8(3). e57542–e57542. 75 indexed citations
16.
Ivanovic, Marina, Michael P. Gailey, Swati Dhar, et al.. (2013). Abstract 4: Nuclear MTA1 overexpression is associated with aggressive prostate cancer and metastasis in African American men.. Cancer Research. 73(8_Supplement). 4–4. 1 indexed citations
17.
Li, Kun, Agnes M. Rimando, Swati Dhar, et al.. (2013). Trimethoxy-Resveratrol and Piceatannol Administered Orally Suppress and Inhibit Tumor Formation and Growth in Prostate Cancer Xenografts. The Prostate. 73(11). 1135–1146. 71 indexed citations
18.
Dhar, Swati, Chindo Hicks, & Anait S. Levenson. (2011). Resveratrol and prostate cancer: Promising role for microRNAs. Molecular Nutrition & Food Research. 55(8). 1219–1229. 101 indexed citations
19.
Dhar, Swati & Shubhada Chiplunkar. (2010). Lysis of aminobisphosphonate-sensitized MCF-7 breast tumor cells by Vγ9Vδ2 T cells.. PubMed. 10. 10–10. 40 indexed citations
20.
Chiplunkar, Shubhada, Swati Dhar, Daniela Wesch, & Dieter Kabelitz. (2009). γδ T Cells in Cancer Immunotherapy: Current Status and Future Prospects. Immunotherapy. 1(4). 663–678. 38 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Valentina Grossi Breakdown of academic impact, for papers by Madhavi Sekharam Breakdown of academic impact, for papers by Toran Sanli Breakdown of academic impact, for papers by Belén Santiago‐Josefat Breakdown of academic impact, for papers by Yingze Wei Breakdown of academic impact, for papers by Peng Meng Breakdown of academic impact, for papers by Young Gyoon Chang Breakdown of academic impact, for papers by Mercedes Nadal‐Serrano Breakdown of academic impact, for papers by Jingjie Yi Breakdown of academic impact, for papers by Kathryn J. Huber-Keener
Rankless by CCL
2026